600267 海正藥業
按盤價 
11.390 +1.040 (+10.048%) | 2025/12 - 人民幣(K¥) | 變動 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 10,549,641 | 2.03% | 10,052,578 | 11,379,008 | 11,572,039 | 11,354,396 | |
| 減：營業總成本 | 9,450,690 | -1.25% | 9,822,174 | 10,603,997 | 10,932,531 | 10,761,673 | |
| 其中:營業成本 | 5,819,865 | -2.19% | 5,876,575 | 6,347,006 | 6,626,577 | 6,441,030 | |
| 財務費用 | 84,036 | -34.83% | 191,673 | 262,748 | 331,253 | 412,503 | |
| 資產減值損失 | (213,172) | -2.67% | (285,522) | (126,037) | (109,431) | (75,337) | |
| 公允價值變動收益 | (34,783) | 133.03% | 278 | (107,318) | (17,769) | 731 | |
| 投資收益 | (36,698) | -123.31% | 74,304 | 31,079 | 104,264 | 34,437 | |
| 其中：對聯營企業和合營企業的投資收益 | (26,177) | -603.21% | (60,373) | (157,554) | (75,745) | (33,679) | |
| 營業利潤 | 867,036 | 20.20% | 89,443 | 682,478 | 700,070 | 776,864 | |
| 利潤總額 | 815,376 | 13.55% | (82,867) | 683,423 | 644,191 | 904,142 | |
| 減：所得稅費用 | 267,890 | 111.34% | 14,148 | 192,188 | 133,272 | 180,975 | |
| 淨利潤 | 547,486 | -7.41% | (97,015) | 491,234 | 510,919 | 723,167 | |
| 減：非控股權益 | 6,778 | -168.67% | (3,844) | 2,374 | 23,743 | 305,973 | |
| 股東淨利潤 | 540,708 | -10.06% | (93,171) | 488,860 | 487,177 | 417,194 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.460 | -11.54% | -0.080 | 0.420 | 0.430 | 0.430 | |
| 每股派息 (元) * | 0.210 | 0.00% | -- | 0.170 | 0.140 | 0.050 | |
| 每股淨資產 (元) * | 7.180 | 3.19% | 6.425 | 6.385 | 5.748 | 6.917 | |
| 審計意見 # | 标准无保留意见 | 保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 15/04/2026 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
